---
title: "GitHub And Investor Readiness Audit"
status: "active"
version: "1.0.0"
last_updated: "2026-04-02"
tags: [verification, github, investor, audit]
role: documentation
---

# GitHub And Investor Readiness Audit

Date: 2026-04-02

## Purpose

Validate whether the standalone MRI Second Opinion repository is shaped correctly for public GitHub review and early investor due diligence under current April 2026 best practices.

## Method

1. Local audit of repository surfaces: root governance files, workflows, package metadata, Docker baseline, and dependency freshness.
2. External fact-check against current official sources for GitHub repository hygiene, OpenSSF trust signals, Node.js release posture, and major framework upgrade readiness.
3. Donor-contamination search across author-owned repository surfaces: `README.md`, `docs/**`, `src/**`, `worker/**`, and `.github/**`.

## Official sources consulted

| Domain | Source | Why it matters |
|---|---|---|
| GitHub community standards | GitHub Docs: `About community profiles for public repositories` | Confirms which community-health surfaces improve repository trust and discoverability |
| GitHub metadata | GitHub Docs: `Classifying your repository with topics` | Confirms topic limits and topic-format rules for public discovery |
| OSS trust signals | OpenSSF Best Practices Badge Program | Confirms current best-practice badge program and public trust-signal baseline |
| Runtime baseline | Node.js Releases page | Confirms Node 24 is Active LTS and Node 25 is Current as of April 2026 |
| Express major migration | Express official `Moving to Express 5` guide | Confirms Express 5 is stable but not a drop-in upgrade |
| Validation library major migration | Zod 4 official release notes | Confirms Zod 4 is stable and materially breaking versus Zod 3 |
| Compiler baseline | TypeScript official blog | Confirms TypeScript 6.0 is available as of March 2026 |

## Findings before remediation

### Strengths already present

1. The standalone repository already has strong public-community surfaces: `README.md`, `LICENSE`, `CODE_OF_CONDUCT.md`, `SECURITY.md`, `CONTRIBUTING.md`, `SUPPORT.md`, and `GOVERNANCE.md`.
2. CI and docs-governance workflows already exist and the evidence ledger records prior hosted passes.
3. The documentation set already contains credible executive, academic, regulatory, security, and verification material.

### Gaps identified

1. Investor-facing material existed, but it was dispersed across multiple documents with no single due-diligence entrypoint.
2. The repository had no `CODEOWNERS` file, which weakened review-routing and ownership signaling.
3. The repository had no dedicated release-packaging workflow despite already generating a CycloneDX SBOM locally.
4. The standalone baseline still targeted Node 22 even though official Node guidance now places 24 in Active LTS.

### Dependency freshness

Patch-level updates were available and safe to absorb inside the current branch for:

1. `@aws-sdk/client-s3`
2. `@aws-sdk/s3-request-presigner`
3. `express-rate-limit`
4. `@types/node` within the Node 24 line

Major-version updates were available but not safe as same-session patch work:

1. `express@5`
2. `zod@4`
3. `typescript@6`

### Why the major migrations were deferred

`zod@4` is not a metadata-only bump for this repository. The current `src/validation.ts` uses Zod 3-specific surfaces such as `required_error`, `invalid_type_error`, and `errorMap`, which the official Zod 4 migration guidance changes materially. That makes Zod 4 a dedicated compatibility wave rather than a safe publication-day patch.

`express@5` is also not a blind upgrade. The official migration guide is explicit that Express 5 preserves the general API shape but still contains breaking changes and should be adopted via automated tests plus targeted fixes.

### Donor-contamination audit

Searches for cable-manufacturing and donor-specific terms such as `cable`, `кабель`, `SynAPS`, `Syn-APS`, `APS platform`, `job shop`, and `manufacturing` produced no author-surface matches in:

1. `README.md`
2. `docs/**`
3. `src/**`
4. `worker/**`
5. `.github/**`

The only matches came from dependency files inside `node_modules` or from the generic word `applicable`, which is not donor contamination.

## Remediation applied in this change

1. Added `docs/investor/README.md` as a stable investor and technical due-diligence router.
2. Added `.github/CODEOWNERS` as the current minimal ownership surface.
3. Added `.github/workflows/release.yml` for reproducible build, test, SBOM generation, and release-asset upload.
4. Moved the standalone runtime baseline to Node 24 LTS across package metadata, CI, and Docker.
5. Refreshed safe patch-level dependencies while leaving major-version migrations for dedicated follow-on work.
6. Extended docs-governance to protect the new investor and release-governance surfaces.

## Remaining open items

1. Re-run hosted `ci`, `docs-governance`, and the new `release` workflow on the current head.
2. Execute a dedicated `express@5` migration wave with route and middleware regression proof.
3. Execute a dedicated `zod@4` migration wave with validation-schema and error-surface updates.
4. Evaluate `typescript@6` only after the runtime-hardening branch settles.
5. Continue the existing clinical-evidence roadmap; this audit does not change RUO posture or claim boundaries.

## Conclusion

After the April 2026 remediation set, the standalone MRI repository is materially better aligned with current public-GitHub and investor-review expectations: it has a clearer due-diligence path, stronger governance signals, an explicit release-packaging lane, a current LTS runtime target, and no evidence of cable-manufacturing donor contamination in author-owned repository surfaces.

The repository remains honestly positioned as `PUBLIC_GITHUB_READY`, not as clinically validated or production-ready.
